The synthesis and characterization of ethylenediamine-modified Elsinochrome A
Source abstract
Abstract
Abstract To overcome the lack of appreciable absorption in the phototherapeutic window (600–900 nm) of the naturally occurring perylenequinonoid pigment, Elsinochrome A , which limits its clinical application, an ethylenediamine-modified elsinochrome A, possessing long wavelength absorption (708 nm) was synthesized. Electron paramagnetic resonance and chemiluminescence assays indicated that ethylenediamine-modified Elsinochrome A possessed photosensitizing activity and its photodamage efficacy is greater than that of unmodified Elsinochrome A .
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Innovative Microfluidic and Catalytic Techniques Innovation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (22)
Show source-provided references
1. Research at the interface between chemistry and virology: development of a molecular flashlight10.1021/cr9500139 ↗
2. Preparation and photodynamic properties of water-soluble hypocrellin A-silica nanospheres10.1016/j.matlet.2008.01.126 ↗
3. Photodynamic properties of a bispyrrolecarboxamide-modified hypocrellin B: the role of affinity and ascorbic acid10.1021/jp7121467 ↗
4. Hypocrellin-based photodynamic sensitizers
5. Photodynamic properties of hypocrellin A, complexes with rare earth trivalent ions: role of the excited state energies of the metal ions10.1021/jp067020t ↗
6. Recognition of various biomolecules by the environment-sensitive spectral responses of hypocrellin B10.1039/b618678e ↗
7. Spectroscopic studies of the interaction between hypocrellin B and human serum albumin10.1016/j.bmc.2005.11.022 ↗
8. Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update10.1111/j.1751-1097.1997.tb01915.x ↗
9. Photodynamic inhibitory effects of three perylenequinones on human colorectal carcinoma cell line and primate embryonic stem cell line10.3748/wjg.v9.i3.485 ↗
10. Photosensitization by anticancer agents 21: new perylene- and aminonaphthoquinones10.1016/0891-5849(95)02061-6 ↗
11. Pigments of Elsinoe species. Part III. Methylation of elsinochrome A. Formation of mono- and di-methyl ethers10.1039/j39700002152 ↗
12. A theoretical study on physicochemical properties of elsinochrome A in ground state10.1016/j.theochem.2005.04.002 ↗
13. Photophysical and photosensitive properties of Elsinochrome A10.1007/s11434-006-1050-3 ↗
14. Photodynamic properties of dipeptide-modified hypocrellin B derivatives: the role of tyrosine and tryptophan groups10.1021/jp066301y ↗
15. Synthesis of a hypocrellin B-polyamide conjugate as DNA-targeting photosensitizer10.1016/j.cclet.2007.11.013 ↗
16. A novel hypocrellin B derivative designed and synthesized by taking consideration to both drug delivery and biological photodynamic activity10.1016/j.jphotobiol.2008.11.008 ↗
17. Prediction on amphiphilicity of hypocrellin derivatives10.1360/02yb9033 ↗
18. A novel method for the preparation of amino-substituted hypocrellin B10.1016/S0960-894X(01)00360-2 ↗
19. Effect of chelation to lanthanum ions on the photodynamic properties of Hypocrellin A10.1021/jp0522563 ↗
20. Chemiluminescence determination of ultramicro DNA with a flow-injection method10.1016/j.aca.2003.11.040 ↗
21. Synthesis and characterization of the monomer ruthenium complex of hypocrellin B10.1016/j.bmcl.2005.04.035 ↗
22. Using electrostatic interactions to increase the photodamaging ability of hypocrellin B: synthesis and study of 2-(dimethylamino) ethanethiol-modied HB10.1039/b616294k ↗